Cancer is reshaping our families, our communities and our world. It is among the leading causes of death globally and cancer rates are increasing for nearly every age group and indication. Despite its prevalence, there is so much left to reveal. Now, a new era of cancer investigation is dawning and powerful whole exome sequencing (WES), which was once prohibitively expensive, is empowering oncology researchers to reveal and understand underlying biology while discovering and exploring novel signatures.
The Whole Exome Sequencing Handbook features:
- Part 1 | Introduce and overview WES and its applications
- Part 2 | Investigate the WES solutions and reagents offered by IDT
- Part 3 | Spotlight key research studies using WES technology
